Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis

    Access Status
    Open access via publisher
    Authors
    Tibolla, G.
    Piñeiro, R.
    Chiozzotto, D.
    Mavrommati, I.
    Wheeler, A.
    Norata, G.
    Catapano, A.
    Maffucci, T.
    Falasca, Marco
    Date
    2013
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Tibolla, G. and Piñeiro, R. and Chiozzotto, D. and Mavrommati, I. and Wheeler, A. and Norata, G. and Catapano, A. et al. 2013. Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis. PLoS ONE. 8 (1): e53808.
    Source Title
    PLoS ONE
    DOI
    10.1371/journal.pone.0053808
    School
    School of Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/28348
    Collection
    • Curtin Research Publications
    Abstract

    The question of whether the distinct isoforms of the family of enzymes phosphoinositide 3-kinases (PI3Ks) play redundant roles within a cell or whether they control distinct cellular processes or distinct steps within the same cellular process has gained considerable importance in the recent years due to the development of inhibitors able to selectively target individual isoforms. It is important to understand whether inhibition of one PI3K can result in compensatory effect from other isoform(s) and therefore whether strategies aimed at simultaneously blocking more than one PI3K may be needed. In this study we investigated the relative contribution of distinct PI3K isoforms to endothelial cells (EC) functions specifically regulated by the sphingolipid sphingosine-1-phosphate (S1P) and by high density lipoproteins (HDL), the major carrier of S1P in human plasma. Here we show that a co-ordinated action of different PI3Ks is required to tightly regulate remodelling of EC on Matrigel, a process dependent on cell proliferation, apoptosis and migration. The contribution of each isoform to this process appears to be distinct, with the class II enzyme PI3K-C2β and the class IB isoform p110γ mainly regulating the S1P- and HDL-dependent EC migration and PI3K-C2α primarily controlling EC survival. Data further indicate that PI3K-C2β and p110γ control distinct steps involved in cell migration supporting the hypothesis that different PI3Ks regulate distinct cellular processes.

    Related items

    Showing items related by title, author, creator and subject.

    • Adenine nucleotide translocase family: Four isoforms for apoptosis modulation in cancer
      Brenner, C.; Subramaniam, K.; Pertuiset, C.; Pervaiz, Shazib (2011)
      Mitochondria have important functions in mammalian cells as the energy powerhouse and integrators of the mitochondrial pathway of apoptosis. The adenine nucleotide translocase (ANT) is a family of proteins involved in ...
    • Novel roles for class II Phosphoinositide 3-Kinase C2ß in signalling pathways involved in prostate cancer cell invasion.
      Mavrommati, I.; Cisse, O.; Falasca, Marco; Maffucci, T. (2016)
      Phosphoinositide 3-kinases (PI3Ks) regulate several cellular functions such as proliferation, growth, survival and migration. The eight PI3K isoforms are grouped into three classes and the three enzymes belonging to the ...
    • Class II phosphoinositide 3-kinase C2ß regulates a novel signaling pathway involved in breast cancer progression.
      Chikh, A.; Ferro, R.; Abbott, J.; Piñeiro, R.; Buus, R.; Iezzi, M.; Ricci, F.; Bergamaschi, D.; Ostano, P.; Chiorino, G.; Lattanzio, R.; Broggini, M.; Piantelli, M.; Maffucci, T.; Falasca, Marco (2016)
      It is now well established that the enzymes phosphoinositide 3-kinases (PI3Ks) have a key role in the development and progression of many cancer types and indeed PI3Ks inhibitors are currently being tested in clinical ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.